The FDA has approved two new biosimilars of denosumab-dssb to treat osteoporosis, increase bone mass, prevent ...

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.

Sarfaraz K. Niazi, PhD, gives his opinion on how the recent IQVIA report “Assessing the Biosimilar Void in the US” could be ...

Number 5: Enzeevu (aflibercept-abzv), a biosimilar developed by Sandoz, demonstrated biosimilarity to reference aflibercept (Eylea) in patients with neovascular age-related macular degeneration (nAMD) ...

For example, in oncology, savings from using biosimilars allows for the reallocation of resources to other critical areas of cancer care, such as diagnostics and other supportive treatments.

As examples of some of the newer, expensive treatments coming through that would need to be funded somehow, Heafield cited CAR-T and gene therapies. NHS biosimilar uptake The NHS has a steep ...

If you have not seen an expert, I recommend a rheumatologist who will perform a careful exam, lots of blood tests, and some X-rays of your knees and back. Once you have a diagnosis, you can get a ...

For example, a pharmacist should never hesitate to assist a patient with obtaining a low-income subsidy. However, when a patient asks a pharmacist or pharmacy employee about which plan is best ...